Misonix, Inc. (MSON): On Watch for the 52W High Breakout

Misonix, Inc. (MSON) announced today its participation in SpineWeek 2012, in Amsterdam, Netherlands. SpineWeek takes place every four years and synchronizes the annual meetings of leading scientific societies, focused on disorders of the spine. SpineWeek had an attendance of over 2,600 individuals, including many recognized leaders in the field from all around the globe.

Misonix provided a showcase for its innovative BoneScalpel™ Ultrasonic Bone Cutting System. More than 75 of physicians requested presentations and/or evaluations of the System at their respective hospitals.

The Misonix BoneScalpel™ is a novel ultrasonic bone cutting tool for rapid, safe and precise osteotomies. It is designed to provide clean cuts through osseous structures with minimal loss of viable bone while sparing adjacent soft tissues, and offered the convenience and speed of a power instrument without the danger associated with rotary sharps. To date, reported uses of the Product in spine surgery include laminectomy, laminotomy, laminoplasty, corpectomy, spinal deformity, foraminotomy, facetectomy and other procedures performed by orthopedic and neuro surgeons.

Michael A. McManus, Jr., President and Chief Executive Officer of Misonix, noted:

We were very pleased to participate in this singular event that brings together researchers and thought leaders from around the globe that specialize in correcting spinal disorders. Exhibiting our state-of-the-art technology at this prestigious gathering further demonstrates our commitment to providing products to the medical community that can directly impact patient outcomes.

MSON’s market capitalization is just a bit over its revenues. Judging by the “low float” nature of Misonix’s stock and aggressive marketing and distribution company strategies the MSON shares may explode at any time on any encouraging event.

Misonix’s recent distribution agreements:

Misonix, Inc.
1938 New Highway
Farmingdale, NY 11735

Tel: (800) 694-9612
Tel: (631) 694-9555
Fax: (631) 694-9412

http://www.misonix.com/

Misonix, Inc. designs, manufactures, develops, and markets minimally invasive ultrasonic medical device products. The company offers BoneScalpel™ cutting system, which is used primarily for surgical procedures of the spine; the SonaStar surgical aspirator used to emulsify and remove soft and hard tumors; and the SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets the AutoSonix ultrasound cutting and coagulating systems, and Lysonix ultrasound assisted liposuction devices. In addition, the company develops and markets Aura ductless fume enclosures for the filtration of gaseous contaminates in the laboratory and forensic markets; and HiSonic ultrasonic technology for the treatment of profound deafness and tinnitus.

Misonix, MSON, SpineWeek